$326,000 Rule 144 stock sale planned in AX (NYSE: AX)

Rhea-AI Filing Summary

An AX shareholder filed a notice to sell 3,260 common shares under Rule 144, with an aggregate market value of $326,000, through Morgan Stanley Smith Barney on or around February 6, 2026 on the NYSE.

The issuer lists 56,678,249 common shares outstanding for this class. The shares to be sold were acquired as restricted stock directly from the issuer on several dates in September 2024 and September 2025, with payment described as not applicable.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3260	326000.00	56678249	02/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock	Issuer			889	09/15/2025	Not Applicable
Common	09/23/2025	Restricted Stock	Issuer			941	09/23/2025	Not Applicable
Common	09/15/2025	Restricted Stock	Issuer			487	09/15/2025	Not Applicable
Common	09/23/2024	Restricted Stock	Issuer			943	09/23/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AX Form 144 filing disclose?

The filing discloses a planned Rule 144 sale of 3,260 AX common shares with an aggregate market value of $326,000. The transaction is to be executed through Morgan Stanley Smith Barney on the NYSE around February 6, 2026.

How many AX shares are planned to be sold under Rule 144?

The notice covers the planned sale of 3,260 AX common shares. These shares have an indicated aggregate market value of $326,000, reflecting the holder’s intention to dispose of a relatively small portion of the company’s equity through a broker-assisted transaction on the NYSE.

What is the aggregate market value of the AX shares in this Form 144?

The aggregate market value of the AX shares covered by this Form 144 is $326,000. This value corresponds to 3,260 common shares listed for sale, providing an indication of the transaction’s scale relative to the issuer’s overall equity capitalization.

How many AX common shares are outstanding according to the filing?

The filing lists 56,678,249 AX common shares outstanding for the class referenced. This figure offers context for the planned sale of 3,260 shares, showing that the contemplated transaction represents a very small portion of the company’s total outstanding equity.

When and how were the AX shares to be sold originally acquired?

The shares to be sold were acquired as restricted stock directly from the issuer on several dates in September 2024 and September 2025. The table notes the nature of payment as not applicable, consistent with stock granted rather than purchased for cash.

Which broker will handle the planned AX share sale disclosed in Form 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filing specifies that the 3,260 AX common shares are intended for sale on the NYSE.